RedHill Biopharma Ltd. (RDHL) Financials
RDHL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 25.3 million | 21.1 million |
| Dec. 31, 2025 | 25.3 million | 21.1 million |
| Sept. 30, 2025 | 25.3 million | 21.1 million |
| June 30, 2025 | 18.4 million | 22.8 million |
RDHL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | ? | ? |
| Sept. 30, 2025 | ? | ? |
| June 30, 2025 | -2.5 million | 148500 |
RDHL Net Income
No data available :(
RDHL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.0 million | - | - |
| Dec. 31, 2025 | 4.0 million | - | 1.1 million |
| Sept. 30, 2025 | 4.0 million | - | 1.1 million |
| June 30, 2025 | 2.9 million | - | 214000 |
RDHL Shares Outstanding
RDHL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | - | - | - |
| Dec. 31, 2025 | - | - | - | - |
| Sept. 30, 2025 | - | - | - | - |
| June 30, 2025 | 2000 | 482000 | 2.9 million | 1.0 million |
RDHL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | 2.0 million | 803500 |
RDHL Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RDHL
Price: $0.57
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Israel
Volume: 100.7 million
Ebitda: -13.8 millionMarket Capitalization: 4.4 million